House E&C Makes FDA Oversight a Priority This Year

Republican legislators on the House Energy and Commerce Committee are setting their sights on cutting red tape, especially at the FDA, as part of their health regulatory priorities in the 113th Congress. Lawmakers are concerned the U.S. is falling behind its global competitors in life sciences due, in large part, to bureaucratic hurdles at the agency.
Drug Industry Daily